loading page

High Incidence Of Fever In Patients After BioIntegral Pulmonic Valved Conduit Implantation
  • +7
  • Arif Selcuk,
  • Yiğit Kılıç,
  • Oktay Korun,
  • Okan Yurdakök,
  • Murat Çiçek,
  • Firat Altin,
  • Yasemin Altuntas,
  • Emine Hekim Yilmaz,
  • Ahmet Sasmazel,
  • Numan Aydemir
Arif Selcuk
Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Author Profile
Yiğit Kılıç
Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Author Profile
Oktay Korun
Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Author Profile
Okan Yurdakök
Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Author Profile
Murat Çiçek
Doktor Siyami Ersek Gogus Kalp ve Damar Cerrahisi Egitim ve Arastirma Hastanesi
Author Profile
Firat Altin
ISTANBUL MEHMET AKIF ERSOY THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL
Author Profile
Yasemin Altuntas
Doktor Siyami Ersek Gogus Kalp ve Damar Cerrahisi Egitim ve Arastirma Hastanesi
Author Profile
Emine Hekim Yilmaz
Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Author Profile
Ahmet Sasmazel
Kartal Kosuyolu Heart Education and Research Hospital
Author Profile
Numan Aydemir
Dr.Siyami Ersek THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL
Author Profile

Abstract

OBJECTIVE The aim of this study is to describe our short-term outcomes using BioIntegral pulmonic conduit. METHODS Between August 2018 and September 2019, the BioIntegral pulmonic valved conduit was used for right ventricular outflow tract reconstruction in 48 patients. The data was retrospectively retrieved from the patient charts. RESULTS The median age at the operation was 36 months (IQR:18-62 months). The diagnoses were PA-VSD in 28 patients, absent pulmonary valve in four patients, truncus arteriosus in six patients, TGA-VSD-PS in five patients, conduit stenosis in three patients and LVOT obstruction requiring Ross operation in two patients. In the postoperative follow-up 15 patients out of 48 had high fever. Out of these, 12 patients had concomitantly elevated CRP levels. There were no patients with blood culture positivity. The median postoperative length of hospital stay was 14 days (IQR:8-21 days). The overall mortality was recorded in 2 patients (4 %), one died due to right ventricular failure and multiple organ failure and one died due to pulmonary embolism. The two patients who died were not among the 15 patients with fever. CONCLUSIONS There was high incidence of fever and adverse outcomes in the short-term postoperative follow-up of the patients in whom the BioIntegral pulmonic valved conduit was implanted. Caution is advisable in using these conduits until there is convincing evidence about the sterilisation and storage standards of these grafts.

Peer review status:ACCEPTED

31 Oct 2020Submitted to Journal of Cardiac Surgery
05 Feb 2021Submission Checks Completed
05 Feb 2021Assigned to Editor
19 Feb 2021Reviewer(s) Assigned
05 Mar 2021Review(s) Completed, Editorial Evaluation Pending
07 Mar 2021Editorial Decision: Revise Minor
02 Apr 20211st Revision Received
03 Apr 2021Submission Checks Completed
03 Apr 2021Assigned to Editor
30 Apr 2021Reviewer(s) Assigned
02 May 2021Review(s) Completed, Editorial Evaluation Pending
03 May 2021Editorial Decision: Accept